GotratixГотратикс
A calf or pig muscle peptide mixture studied alongside regular training in former rowers and track athletes.
What the studies found
Comparison in people · 2011
Gotratix With Regular Training: 2011 Grip and Jump Study
- Right-hand grip
- 47 → 53 kgTraining alone: 46 → 47 kgGotratix group before vs after: p < 0.05
- Left-hand grip
- 42 → 48 kgTraining alone: 43 → 45 kgGotratix group before vs after: p < 0.05
- Standing long jump
- 215 → 231 cmTraining alone: 212 → 219 cmGotratix group before vs after: p < 0.05
At two months, both grip measures and standing long jump improved from baseline in the Gotratix group. Step-test and flexibility changes were nonsignificant.
Report attributed to · Medical Center, St. Petersburg Institute of Bioregulation and Gerontology
More reported outcomes
- Modified step test
- 55 → 58 stepsTraining alone: 53 → 57 stepsChange in the Gotratix group was nonsignificant
- Flexibility
- 7.0 → 9.2 cmTraining alone: 6.3 → 7.5 cmChange in the Gotratix group was nonsignificant
- Tolerability
- The report records no side effects, complications or dependence.The report gives no systematic adverse-event assessment.
Study notes · methods, sources and limitations
Participants or model 37 former athletes aged 40–65 in the signed scan, 20 assigned to Gotratix plus training and 17 to training alone. The analyzed denominator is unclear.
Design Former rowers and track-and-field athletes aged 40–65 continued their regular training. The comparison group trained without Gotratix. Endurance was assessed with a modified Harvard step test, and flexibility with a standing forward bend. Testing sessions were two months apart.
Important limitations
- The signed scan reports 37 participants (20 Gotratix, 17 controls), but its sex counts sum to 27 and the men’s table repeats the full arm sizes. The compiled editions label the Gotratix arm n=22. The report describes no randomization or blinding and gives no statistical comparison of changes between groups. The institute report has no documented independent peer review. Its short tolerability account cannot establish long-term safety or equivalence to current products. The Gotratix and SPORT 5 Plus reports share the study site, dates, tests and nine of ten control-group means and error values. The Gotratix cohort is excluded from the sports participant total because its independence is unverified.
- The report gives no between-group effect estimate, and the numbers analyzed are unclear. The Gotratix and SPORT 5 Plus reports share the study site, dates, tests and nine of ten control-group means and error values. The Gotratix cohort is excluded from the sports participant total because its independence is unverified.
2011 institute report, reproduced by distributors · Institute report — commercial reproduction
About Gotratix
Identity / background source ↗
Research background
Gotratix is a muscle-derived peptide preparation. A Medical Center report measured grip strength, standing long jump and exercise-test results during a two-month training program.
- Compound class
- Tissue-derived peptide preparation
- Research collection
- Peptide bioregulation · editorial grouping
- Institutions in linked studies
- Medical Center, St. Petersburg Institute of Bioregulation and Gerontology
- Source review
- Review dates and the material assessed are listed with each publication below.
Understanding the evidence
Human research
37 former athletes aged 40–65 in the signed scan, 20 assigned to Gotratix plus training and 17 to training alone. The analyzed denominator is unclear.
Study methods
Small comparative institute report; allocation, blinding and outcome interpretation require caution
Independent replication
Independent replication not established in this collection
Source access
Report reproduction linked; source language and review scope shown per record
Safety evidence
Short-term reports do not establish long-term safety or equivalence to current products
Open a topic for the evidence assessment.
Findings by study
Tissue-preparation reports: comparisons, source limits and remaining gaps ↗
Comparison in people · 2011
Gotratix With Regular Training: 2011 Grip and Jump Study
At two months, both grip measures and standing long jump improved from baseline in the Gotratix group. Step-test and flexibility changes were nonsignificant.
Right-hand grip · 47 → 53 kg · Training alone: 46 → 47 kg · Gotratix group before vs after: p < 0.05
Study notes and original source
Gotratix With Regular Training: 2011 Grip and Jump Study
Report attributed to · Medical Center, St. Petersburg Institute of Bioregulation and Gerontology
Tissue-derived mixture / named preparation · Institute report — commercial reproduction
St. Petersburg Institute of Bioregulation and Gerontology Medical Center (report attribution) · 2011 institute report, reproduced by distributors
At two months, both grip measures and standing long jump improved from baseline in the Gotratix group. Step-test and flexibility changes were nonsignificant.
Results and tables
Reported findings and study design
The Gotratix group gained 6 kg in each handgrip test and 16 cm in standing long jump over two months. The report marked all three changes significant from that group’s baseline.
Former rowers and track-and-field athletes aged 40–65 continued their regular training. The comparison group trained without Gotratix. Endurance was assessed with a modified Harvard step test, and flexibility with a standing forward bend. Testing sessions were two months apart.
Population or model 37 former athletes aged 40–65 in the signed scan, 20 assigned to Gotratix plus training and 17 to training alone. The analyzed denominator is unclear.
Dose, route and schedule
The signed Russian report describes two oral 10 mg capsules twice daily with meals for 30 days (40 mg/day). Both groups continued their usual training.
Protocol source ↗ · Russian report, group procedures and capsule strength
| Measure | Result | Comparison, timing and statistics |
|---|---|---|
| Right-hand grip | 47 → 53 kg | Training alone: 46 → 47 kg · Gotratix group before vs after: p < 0.05 |
| Left-hand grip | 42 → 48 kg | Training alone: 43 → 45 kg · Gotratix group before vs after: p < 0.05 |
| Standing long jump | 215 → 231 cm | Training alone: 212 → 219 cm · Gotratix group before vs after: p < 0.05 |
| Modified step test | 55 → 58 steps | Training alone: 53 → 57 steps · Change in the Gotratix group was nonsignificant |
| Flexibility | 7.0 → 9.2 cm | Training alone: 6.3 → 7.5 cm · Change in the Gotratix group was nonsignificant |
| Tolerability | The report records no side effects, complications or dependence. | The report gives no systematic adverse-event assessment. |
2011 exercise-test table
| Measure | Gotratix + training, first test | Gotratix + training, second test | Training alone, first test | Training alone, second test |
|---|---|---|---|---|
| Right-hand grip (kg) | 47 ± 2.1 | 53 ± 3.9* | 46 ± 1.4 | 47 ± 1.6 |
| Left-hand grip (kg) | 42 ± 1.7 | 48 ± 1.4* | 43 ± 1.3 | 45 ± 1.8 |
| Standing long jump (cm) | 215 ± 4 | 231 ± 3* | 212 ± 6 | 219 ± 6 |
| Step test (steps) | 55 ± 3.1 | 58 ± 6.8 | 53 ± 6.3 | 57 ± 7.5 |
| Flexibility (cm) | 7.0 ± 1.1 | 9.2 ± 2.1 | 6.3 ± 2.1 | 7.5 ± 1.7 |
Values are reproduced as M ± m. An asterisk marks p < 0.05 against the first test within the same group. The signed scan labels the table as results in men but lists the full study arm sizes.
The report gives no between-group effect estimate, and the numbers analyzed are unclear. The Gotratix and SPORT 5 Plus reports share the study site, dates, tests and nine of ten control-group means and error values. The Gotratix cohort is excluded from the sports participant total because its independence is unverified.
Source for these results ↗ · Reviewed 2026-11-15
- Population / setting
- 37 former athletes aged 40–65 in the signed scan, 20 assigned to Gotratix plus training and 17 to training alone. The analyzed denominator is unclear.
- Source reviewed
- Methods and numerical table checked against the signed Russian scan and both reprints. The treated-arm count differs by edition.
Study limitations
- The signed scan reports 37 participants (20 Gotratix, 17 controls), but its sex counts sum to 27 and the men’s table repeats the full arm sizes. The compiled editions label the Gotratix arm n=22.
- The report describes no randomization or blinding and gives no statistical comparison of changes between groups.
- The institute report has no documented independent peer review. Its short tolerability account cannot establish long-term safety or equivalence to current products.
- The Gotratix and SPORT 5 Plus reports share the study site, dates, tests and nine of ten control-group means and error values. The Gotratix cohort is excluded from the sports participant total because its independence is unverified.
Reviewed 2026-11-15.
Related compound research
Follow shared publications or research classes. These links do not establish equivalent effects between compounds.
Research collection curated by @PepMariner · editorial standards. Send a source correction ↗
Browse bibliography & PDFs ↗